Ms. Kelly Baldwin, LCMHC Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 244 High Watch Rd, Effingham, NH 03882 Phone: 603-230-2448 |
Mr. William Piers Kaniuka, MA, MTS Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 244 High Watch Rd, Effingham, NH 03882 Phone: 603-539-8808 |
Kelly Lane Whitman, LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 244 High Watch Rd, Effingham, NH 03882 Phone: 603-539-8743 |
News Archive
Drugs already in development to treat Alzheimer's disease may eventually be tapped for a different purpose altogether: re-growing the ends of injured nerves to relieve pain and paralysis.
A&G Pharmaceutical announced today that it has received $1.2 million in Phase II Small Business Innovation Research (SBIR) funding from the National Cancer Institute (NCI) for the program, "Novel Targeted Therapy for Breast Cancer," focused on the development of a neutralizing therapeutic antibody against a novel cancer-associated protein, GP88.
Dr. Richard Lock, Head of the Leukaemia Biology Program at the Children's Cancer Institute Australia for Medical Research, Sydney, along with collaborators from the Childrens Hospital Los Angeles and University of Southern California, USA, recently published their findings in the prestigious scientific journal Blood.
Nestlé S.A. (Nestlé) announced the creation of Nestlé Skin Health S.A., a global leader focused on meeting the world's increasing skin health needs with a scientifically-proven broad range of innovative products.
The incidence of melanoma, a deadly form of skin cancer, has increased by more than 250% among children, adolescents and young adults since 1973, according to award-winning research to be presented by Roswell Park Cancer Institute (RPCI) at the American Society of Clinical Oncology (ASCO) 51st Annual Meeting in Chicago.
› Verified 3 days ago